# vyasa.com

> AI-optimized mirror of vyasa.com containing 48 pages totalling 4,171 words of clean markdown content, structured data, and semantic HTML. Original source: https://vyasa.com/. Last updated: 2026-06-15T01:25:40.507Z.

Each page is available as HTML (with JSON-LD structured data) and Markdown (text-only, ideal for LLMs and RAG).

## Homepage

- [Certara | Drug Development Solutions](/content/site-root.html): Certara's transformative drug development solutions include data-driven modelling, AI and predictive simulation. Accelerate your development process for good (1 words)
- [AI](/content/site-root.html): Use Certara's AI platform for Life Sciences to solve data silo problems while improving analytics capabilities that boost productivity. (65 words)

## Articles & Blog Posts

- [resources/learning-center/index.html](/content/resources/learning-center/index.html) (1 words)
- [Best Practices for pharma commercialization in market access](/content/resources/market-access-commercial/index.html) (103 words)
- [Regulatory products](/content/solutions/regulatory/index.html): Regulatory affairs solutions that simplify your path to market, prevent delays & support your regulatory affairs team in ensuring compliance and approval. (307 words)
- [Greater Certainty in Drug Development | The Certara Story](/content/our-story/index.html): Certara advances drug development, new drug applications, regulatory science and market access solutions. Find out more about our history... (1 words)
- [Executive Leadership Team | Certara](/content/leadership/index.html): Discover the visionary leaders guiding Certara's mission to transform drug development and accelerate medicines to patients. (1 words)
- [IQ™](/content/software/quantitative-systems-pharmacology/index.html): Certara IQ is an AI-enabled QSP modeling software that scales quantitative systems pharmacology, offering validated models, workflows, and regulatory-ready insights. (144 words)
- [QSP Modeling for Parkinson’s Disease: Solving the Synthetic Control Challenge in Clinical Trials](/content/resources/blogs/index.html): Gain invaluable pharmaceutical insights with our drug development blog, featuring expert tips and best practices. Discover our transformative blogs here. (328 words)
- [[Machine Learning for PK/PD Modeling in Drug Development](https://www.certara.com/blog/machine-learning-for-pk-pd-modeling-in-drug-development/)](/content/resources/early-clinical/index.html) (167 words)
- [Certara Services | Best practices in new drug development](/content/services/index.html): Discover Certara's tailored drug discovery and development services, from predictive modeling to market access strategies. Learn more today... (1 words)
- [Certara | Regulatory Adoption in Drug Development](/content/company/regulatory-adoption/index.html): Certara’s contributions have supported >250 drug label claims. Our customers have received >90% of all novel drug approvals by the FDA from 2014 to 2024. (57 words)
- [Machine Learning for PK/PD Modeling in Drug Development](/content/resources/preclinical/index.html) (142 words)
- [Clinical Validation of a QSP Model for ISB 2001, a Trispecific T Cell Engager to Support Optimal FIH Study Design in RRMM Patients](/content/resources/publications/index.html): Research authored by scientists at Certara (464 words)
- [Recapping a record-breaking 2025 Krakow HTA Symposium](/content/resources/late-clinical/index.html) (167 words)
- [Empowering Biotech leaders to drive innovation](/content/solutions/strategic-leadership/index.html): Certara Strategic Leadership will empower you to deliver therapies by unifying siloed development activities, standardizing data and insights across phases (72 words)
- [Early clinical products](/content/solutions/early-clinical/index.html): Improve your trials' chance of success at early clinical development and accelerate your journey towards approval. Learn more in a case study at Phase 1 trials (220 words)
- [[Enhancing Pharmacokinetics Workflows at Charles River](https://www.certara.com/case-study/enhancing-pharmacokinetics-workflows-at-charles-river/)](/content/resources/index.html): Certara’s Resource Library contains the latest resources, thought leadership, and best practices for the global biopharmaceutical industry. (57 words)
- [Chemaxon®](/content/chemaxon/index.html): A complete cheminformatics workbench for molecule design, property calculation, search, data management, and more. (74 words)
- [Worldwide Locations & Offices | Certara](/content/company/our-locations/index.html): Explore Certara's global presence with offices in North America, Europe, and Asia-Pacific, including headquarters in Radnor, PA. (5 words)
- [Regulatory resources | Certara](/content/resources/regulatory/index.html) (8 words)
- [Related products and services](/content/basecase/index.html): Our Value Communication Software empowers market access pharma teams with interactive tools to showcase product value. (47 words)
- [Conferences | Certara](/content/resources/conferences/index.html): Certara is a proud sponsor at many conferences and is honored to present thought leadership sessions on many topics including biosimulation, clinical pharmacology, PKPD, PBPK modeling, CDISC, regulatory topics and market access. (1 words)
- [Discover more Certara services](/content/services/early-development/regulatory-affairs-consulting/index.html): Our Regulatory Affairs Consulting team offers standalone services & integrated support from product development to commercial and lifecycle maintenance. (41 words)
- [Real-world Evidence and Market Access Services](/content/evidence-access/index.html): Our Pharmaceutical Market Access team optimizes product value, positioning, and evidence synthesis through all stages of reimbursement including HEOR, RWE, etc (10 words)
- [company/index.html](/content/company/index.html) (1 words)
- [Phoenix®](/content/software/phoenix-pkpd/index.html): The industry's most trusted pharmacokinetics software for non-compartmental analysis (NCA), population PK (popPK), IVIVC, and more. Learn more... (213 words)
- [Therapeutic Area Services | Certara](/content/services/therapeutic-areas/index.html): Explore our Therapeutic Area Services and tap into unmatched therapeutic area expertise in Clinical Development. Find our full list of service areas here. (1 words)
- [Certara Customers | Customer Success Stories](/content/customers/index.html): Certara partners with top global pharmaceutical companies, emerging biotechs, and regulatory agencies to transform drug development for good. (1 words)
- [Simcyp®](/content/simcyp-overview/index.html): Our PBPK modeling software is the most widely adopted platform for PBPK modeling in drug development. Find out more about our Simcyp® Platform here. (111 words)
- [Webinars | Certara](/content/resources/webinars/index.html): Check out our upcoming scientific webinars for more details and registration information. (3 words)
- [Drug Development Services](/content/services/drug-development-services/index.html): Engage with Certara's drug development consulting to streamline your development with tailored strategies for non-clinical, clinical and CMC phases (13 words)
- [Preclinical products](/content/solutions/preclinical/index.html): We successfully navigate preclinical drug development with sophisticated expertise and biosimulation technologies to streamline CTA and IND submissions success (211 words)
- [Certara Partner Program | Become a Certara Partner](/content/company/partners/index.html): Find out all about the Certara Partner Program and learn how our partners help bring new therapies and solutions to market. (1 words)
- [Certara discovery products](/content/solutions/discovery/index.html): Certara's drug discovery software will accelarate breakthroughs with biosimulation and predictive modeling to refine candidates and improve preclinical success (122 words)
- [Model-Informed Drug Development​ Solutions | Certara](/content/solutions/midd/index.html): Partner with Certara for expert MIDD consulting that accelerates decision-making, reduces development risk, and supports regulatory success. (1 words)
- [Pinnacle 21®](/content/pinnacle-21-enterprise-software/index.html): Improve clinical data quality & compliance from setup to submission with Pinnacle 21® Enterprise validation and clinical data standardization software. (12 words)
- [Modeling and Simulation Services](/content/services/modeling-and-simulation-services/index.html): Our Modeling and Simulation services optimize drug development and increase confidence for critical decisions using Predictive Biosimulation and Modeling (11 words)
- [Late clinical products](/content/solutions/late-clinical/index.html): Ensure your drug's market approval submission at late stage pharmaceutical development with us. Learn how we help teams to optimise their phase 2 and 3 trials (171 words)
- [Certara Drug Development Software | Clinical Trial Software](/content/software/index.html): The industry's leading provider of drug development software from discovery to market access. Our software include Simcyp, Phoenix, Pinnacle 21... (1 words)
- [GlobalSubmit™](/content/globalsubmit-ectd-submission-software/index.html): Publish, validate, and review your eCTD submissions with GlobalSubmit eCTD Software, eliminating risk and expediting regulatory acceptances. (59 words)
- [Related products](/content/d360-scientific-informatics-platform/index.html): D360 is the industry leading Scientific Informatics Platform for small molecule and biologics discovery research. (86 words)
- [Related products and services](/content/coauthor/index.html): Increase the efficiency of regulatory and medical writing with Certara’s purpose-built Generative AI-Enabled Writing Software. (94 words)
- [Related products and services](/content/send-explorer-software/index.html): SEND Explorer® software enables advanced visualization, summarization & analysis of nonclinical study data produced in SEND format. (106 words)
- [Our offerings for navigating animal alternatives](/content/solutions/non-animal-navigator/index.html): Explore innovative alternatives to animal testing with Certara's Non-Animal Navigator™. Harness expert strategy and AI-enabled biosimulation. (93 words)
- [Pharmaceutical Development Solutions | Certara](/content/solutions/index.html): Pharmaceutical development solutions to transform your drug development journey. We integrate tech, science and strategic expertise to solve your challenges (1 words)
- [Not Just Another ChatGPT: Why Life Sciences Needs Domain-Specific AI](/content/resources/discovery/index.html) (195 words)
- [Market access and commercial products](/content/solutions/market-access-and-commercial/index.html): Our market access solutions demonstrate value and enable you to optimize pricing for global patient access (180 words)

## Resources

- [Full Page Index](/index.html): Browse all cached pages with rich metadata
- [About This Cache](/content/about.html): Methodology, technical details, and usage guidelines
- [XML Sitemap](/sitemap.xml): Machine-readable sitemap for crawler discovery
- [Robots.txt](/robots.txt): Crawler directives